Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isracann Biosciences Inc ISCNF

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.


GREY:ISCNF - Post by User

Bullboard Posts
Comment by marexxxon Dec 17, 2019 1:29am
252 Views
Post# 30462246

RE:Isracann

RE:IsracannVery good post, takeover may and probably will happen but this will be majority shareholders decision, and you absolutely right….. if takeover happens then we will be talking Dollars not cents.
 
I look at facts and I made my own decision…. I’m in!
 
“Investing in Israeli cannabis isn’t a dumb thing from the outset.
But who has the ability to grow there?
 
You’d need a license – not an application, but a real actual license.
And you’d need land you could build greenhouses on.
And you’d need the money to build those greenhouses.
 
Isracann has all three and $15 Mil on hands.
In fact, it has agreements with three Israeli license holding farms, and it has a fully funded greenhouse capacity of 232k sq ft, and 348k sq ft more to grow into later.”
 
And who’s running IPOT?…..
 
Daryl Jones is President and CEO. You may recall him from being the guy who took True Leaf (MJ.C) public in 2014, and exiting three years later with a 15x profit.
 
Brett Allan, who was part of the team that brought Emblem Health (EMC.V), Organigram (OGI.T), and Green Organic Dutchman (TGOD.T) public, is an advisory board member.
 
Happy investing!

Bullboard Posts